Mar 31, 2025

Public workspaceFetal Calf Serum (FCS / FBS) Protein Binding

  • Yurii Kheilik1,
  • Yaroslav Lesyk1,
  • Nadiia Diyuk1
  • 1Enamine Ltd
  • ASAP Discovery
Icon indicating open access to content
QR code linking to this content
Protocol CitationYurii Kheilik, Yaroslav Lesyk, Nadiia Diyuk 2025. Fetal Calf Serum (FCS / FBS) Protein Binding. protocols.io https://dx.doi.org/10.17504/protocols.io.e6nvwbzk2vmk/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: December 18, 2024
Last Modified: March 31, 2025
Protocol Integer ID: 116462
Keywords: Fetal calf serum , Dialysis membrane , Protein binding, ADMET, DMPK, FCS, FBS
Disclaimer
The protocol content here is for informational purposes only and does not constitute legal, medical, clinical, or safety advice, or otherwise; content added to protocols.io is not peer reviewed and may not have undergone a formal approval of any kind. Information presented in this protocol should not substitute for independent professional judgment, advice, diagnosis, or treatment. Any action you take or refrain from taking using or relying upon the information presented here is strictly at your own risk. You agree that neither the Company nor any of the authors, contributors, administrators, or anyone else associated with protocols.io, can be held responsible for your use of the information contained in or linked to this protocol or any of our Sites/Apps and Services.
Abstract
In vitro pharmacological and toxicological evaluation of chemicals is performed using a wide variety of cell‐based assay systems. One of the major factors influencing the in vitro responses of chemicals is the amount of unbound chemicals present at the target site. The concentrations of the unbound chemicals primarily depend on the protein levels and their binding affinities. Fetal calf/bovine serum (FCS / FBS) Protein binding assay is used in cell culture in cell biology research and in the pharmaceutical industry to support this analysis.

Assay to Determine Protein binding in fetal calf / bovine serum (FCS / FBS) capabilities for compounds and reference compound (Verapamil) - In 2% heat-inactivated FCS (30 min, 56ºC) using HPLC-MS/MS. The task was performed by spiking test compounds at a concentration of 1 μM into 2% FCS and dialyzing against buffer until equilibrium is achieved. Peak areas of the compound in both 2% FCS and buffer were determined to calculate the percentage of protein-bound compound.
Materials
Equipment:

  • HPLC system with mass spectrometric detector API4000/API5000.
  • Incubator Series II Water Jacketed CO2 incubator.
  • Multi-channel automatic pipettes: 2-125 µL, 1-30 µL, 15-1250 µL, E1-ClipTip.
  • Reusable dialyzer HTD96b.
  • Dialysis membrane strips (HTDialysis LLC, USA; cat. no. 1101).
  • Disposable tips for Thermo automatic pipettes Scientific Cliptip.
  • Polypropylene tubes in a 96-well rack, 0.75 ml.
  • Silicone 96-well micromats with a round bottom, pre-perforated.

Reagents:

  • 100 mM (1x) Potassium phosphate buffer (PPB), pH 7.4
  • RPMI medium with 10% Fetal Bovine Serum (FBS / FCS)
  • Compounds stock solutions: prepare 20 mM stocks of reference and test compounds in DMSO. Then, dissolve DMSO stock in acetonitrile (ACN) to 100 μM, and mix by vortexing.
  • Quenching solution with internal standards.
  • Dissolve appropriate for LC-MS/MS analysis internal standards in ACN.

Safety warnings
Always wear appropriate PPE for this protocol
Refer to Material Safety Data Sheets for additional safety and handling information.
Samples Preparation
Samples Preparation
6h 5m
6h 5m
Preparation of Phosphate-buffered saline (PBS):
PBS Concentration10 millimolar (mM) (1X), pH 7.4. To prepare 10X (Concentration100 millimolar (mM) ), the buffer packet is first dissolved in Amount50 mL of MilliQ water. Filter the solution with a syringe filter, store at Temperature4 °C no more than 4 weeks. Before the test, dilute the 10X solution to the working concentration of 1X (Concentration10 millimolar (mM) ), bring the pH to 7.4. Concentration1 Molarity (M) PBS store at Temperature4 °C no more than 7 days.

Preparation of RPMI medium with 10% FBS / FCS:
To prepare Amount1 L of basic basicliquid medium from this item would require Amount10.4 g of the powder product plus the addition of Amount2 g of sodium bicarbonate. рН is regulated in a range of 7.3-7.6. Then media is filtered through PES filter-cup with 0.22 um pores. After the prepation of basic media the heat-inactivated FBS is added in a final concentration of 10%. рН is regulated in a range of 7.3-7.6. Then media is filtered through PES filter-cup with 0.22 um pores. After the prepation of basic media the heat-inactivated FBS is added in a final concentration of 10%.

ACN stock, Concentration100 micromolar (µM) :

Add Amount995 µL of acetonitrile and Amount5 µL of Concentration20 millimolar (mM) DMSO stock substance to a 1.4 mL microtube, mix by pipetting. Store no more than two weeks at Temperature4 °C .

Pipetting
Mix
Preparation of dialysis membrane:
Before the test, cut off the required amount of the membrane strip, cut it lengthwise so that after soaking, they are divided into two single strips (Fig. 1). Place the membrane in MilliQ water or PBS for Duration01:00:00 . Divide the soaked membrane into two single strips.

Note
WARNING! Make sure only a single sheet of dialysis membrane is placed between Teflon bars.

Fig. 1. Scheme of cutting the dialysis membrane before soaking.

1h
Assembling the Teflon bars with dialysis membrane:
Lay the first Teflon bar flat on the bench (Fig. 2), insert the two stainless steel connecting rods so they are perpendicular to the Teflon bar. Place the membrane on the Teflon bar. Ensure that the membrane is approximately 2mm below the top edge of the bar and the lower membrane edge overlaps the bottom of all wells (Fig. 2a).



Assembly of dialysis machine:
Take the machine and make sure that it is in the open position (Fig. 3). Insert the Teflon block into the machine and the pressure plate between the Teflon block and the pressure shaft as in (Fig. 3a). Tighten the assembled block, evenly rotating the cam levers with both hands (Fig. 3b).



Carrying out the test:
Prepare Concentration1 micromolar (µM) model solutions of substances in RPMI medium with 10% FBS. Add Amount3 µL ACN substance in Amount297 µL of RPMI medium with 10% FBS (Fig. 4 ). Mix by pipetting 4-5 times, pouring down the wall of the test tube.

Fig. 4 Scheme of arrangement of microtubes in the plates

Pipetting
Mix
Add Amount125 µL of solutions of substances in RPMI medium with 10% FBS to the donor cells of the machine (Fig. 5 ). Add Amount50 µL each of model solution and PBS in the 'Stability' microtubes of the final 96-well plate. Quench the solution in microtubes 'Stability' with Amount400 µL IS solution, mix on a vortex and store at Temperature4 °C until analysis.

Fig 5. Schematic of a collective dialysis device

Pipetting
The dialysis device and model solutions in a CO2 incubator and at 250 rpm and Temperature37 °C for Duration05:00:00 .

Note
WARNING! Most compounds reach equilibrium in less than Duration04:00:00 -Duration05:00:00 at Temperature37 °C shaking at 250 rpm. For confidence, you can conduct the following kinetic experiment: compound spike into buffer and dialyze against buffer to evaluate the equilibrium time required prior to initiating any binding experiments.

5h
Incubation
After the incubation
To balance the matrix effect, add Amount50 µL blank RPMI medium with 10% FBS to the recipient tubes and vice versa, in the donor add recovery Amount50 µL of buffer. After that, transfer Amount50 µL of the acceptor solution to recipient tubes, Amount50 µL donor solution into donor tubes, and Amount50 µL of model solution to recovery tubes. All samples should be quenched immediately, by adding Amount400 µL of IS solution in recipient, donor, and recovery tubes. To check specificity and selectivity, should make a blank solution from the RPMI medium with 10% FBS.

Pipetting
And finally, close the test tubes with rubber caps, mix with a vortex and centrifuge for Centrifigation6000 rpm, 00:05:00 . Supernatants are analyzed using the HPLC system coupled with tandem mass spectrometer.

5m
Centrifigation
Mix
Data Analysis
Data Analysis
The percentage of substances bound to FBS proteins recovery and stability are calculated according to the following equations.



The percentage of unbound fraction fu is calculated by the formula: